Stay updated on Immunotherapy for Anal Canal Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.

Latest updates to the Immunotherapy for Anal Canal Cancer Clinical Trial page
- Check7 days agoChange DetectedA Sample Collection item was added on 2026-05-28 to the biospecimen section, expanding the biospecimen collection procedures. A separate entry listed on 2026-04-23 was deleted.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedTwo new study centers were added (University of Michigan Rogel Cancer Center and VCU Massey Comprehensive Cancer Center) while two centers were removed, imaging service terms were updated to Diagnostic CAT Scan Service Type and Diagnostic CAT Scan, and the study's revision was updated from v3.5.3 to v3.5.4.SummaryDifference0.6%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThe page now shows the trial’s updated results status and reporting timeline, including a new “Results Posted” date (2026-04-22) and updated results reporting entries. It also adds/updates the defined outcome measures and their accompanying methodology text for efficacy (ORR, PFS, OS), safety (treatment-related toxicities graded by CTCAE v5.0), and exploratory biomarker analyses.SummaryDifference2%

- Check49 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check78 days agoChange DetectedVersion bump from v3.4.3 to v3.5.0; no changes to study details or patient-facing information.SummaryDifference0.0%

- Check85 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy for Anal Canal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Anal Canal Cancer Clinical Trial page.